These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27752061)

  • 1. Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
    Teng HW; Hung MH; Chen LJ; Chang MJ; Hsieh FS; Tsai MH; Huang JW; Lin CL; Tseng HW; Kuo ZK; Jiang JK; Yang SH; Shiau CW; Chen KF
    Sci Rep; 2016 Oct; 6():35308. PubMed ID: 27752061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
    Tai WT; Chen YL; Chu PY; Chen LJ; Hung MH; Shiau CW; Huang JW; Tsai MH; Chen KF
    Hepatology; 2016 May; 63(5):1528-43. PubMed ID: 26840794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
    Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
    Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-1 is a target of regorafenib in colorectal cancer.
    Fan LC; Teng HW; Shiau CW; Lin H; Hung MH; Chen YL; Huang JW; Tai WT; Yu HC; Chen KF
    Oncotarget; 2014 Aug; 5(15):6243-51. PubMed ID: 25071018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer.
    Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
    Neoplasia; 2015 Sep; 17(9):687-696. PubMed ID: 26476076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ).
    Cordeiro HG; de Sousa Faria AV; Ferreira-Halder CV
    Biol Chem; 2020 Aug; 401(9):1063-1069. PubMed ID: 32229687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis.
    Chen Q; Li Y; Li Z; Zhao Q; Fan L
    J Mol Histol; 2014 Apr; 45(2):153-9. PubMed ID: 23990346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer.
    Ou B; Cheng X; Xu Z; Chen C; Shen X; Zhao J; Lu A
    Cell Death Dis; 2019 Sep; 10(9):643. PubMed ID: 31501414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of protein tyrosine phosphatase 1B in Ras signaling.
    Dubé N; Cheng A; Tremblay ML
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1834-9. PubMed ID: 14766979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
    Camaj P; Primo S; Wang Y; Heinemann V; Zhao Y; Laubender RP; Stintzing S; Giessen-Jung C; Jung A; Gamba S; Bruns CJ; Modest DP
    Future Oncol; 2015; 11(13):1919-29. PubMed ID: 26161928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.
    Hoekstra E; Das AM; Swets M; Cao W; van der Woude CJ; Bruno MJ; Peppelenbosch MP; Kuppen PJ; Ten Hagen TL; Fuhler GM
    Oncotarget; 2016 Apr; 7(16):21922-38. PubMed ID: 26942883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
    Teng HW; Hung MH; Chen LJ; Chang MJ; Hsieh FS; Tsai MH; Huang JW; Lin CL; Tseng HW; Kuo ZK; Jiang JK; Yang SH; Shiau CW; Chen KF
    Sci Rep; 2017 Apr; 7():45612. PubMed ID: 28394314
    [No Abstract]   [Full Text] [Related]  

  • 15. Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.
    Argilés G; Saunders MP; Rivera F; Sobrero A; Benson A; Guillén Ponce C; Cascinu S; Van Cutsem E; Macpherson IR; Strumberg D; Köhne CH; Zalcberg J; Wagner A; Luigi Garosi V; Grunert J; Tabernero J; Ciardiello F
    Eur J Cancer; 2015 May; 51(8):942-9. PubMed ID: 25818084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
    Thiebaut PA; Besnier M; Gomez E; Richard V
    J Mol Cell Cardiol; 2016 Dec; 101():50-57. PubMed ID: 27596049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation.
    Zhang J; Li L; Li J; Liu Y; Zhang CY; Zhang Y; Zen K
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):163-74. PubMed ID: 25395617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.
    Su JC; Mar AC; Wu SH; Tai WT; Chu PY; Wu CY; Tseng LM; Lee TC; Chen KF; Liu CY; Chiu HC; Shiau CW
    Sci Rep; 2016 Jul; 6():28888. PubMed ID: 27364975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
    Napolitano S; Martini G; Rinaldi B; Martinelli E; Donniacuo M; Berrino L; Vitagliano D; Morgillo F; Barra G; De Palma R; Merolla F; Ciardiello F; Troiani T
    Clin Cancer Res; 2015 Jul; 21(13):2975-83. PubMed ID: 25838391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.